Literature DB >> 26755716

Control or overcontrol for covariates?

David L Streiner1.   

Abstract

Covariate adjustment can adjust for baseline differences in randomised controlled trials (RCTs) that may have arisen by chance. Furthermore, even if the groups do not differ significantly on any factors, using baseline variables that may be related to the outcome as covariates can reduce the within-group variance, thus increasing the accuracy of the estimates of treatment effects and the power of the statistical test. However, improper use of covariate adjustment can either magnify or diminish the difference between the groups. In RCTs, covariates must be chosen carefully and should not include variables that may have been affected by the treatment itself. The use of covariate adjustment in cohort studies is even more fraught and may result in paradoxical situations, in which there can be opposite interpretations of the results. Published by the BMJ Publishing Group Limited. For permission to use (where not already granted under a licence) please go to http://www.bmj.com/company/products-services/rights-and-licensing/

Keywords:  EPIDEMIOLOGY; STATISTICS & RESEARCH METHODS

Mesh:

Year:  2016        PMID: 26755716     DOI: 10.1136/eb-2015-102294

Source DB:  PubMed          Journal:  Evid Based Ment Health        ISSN: 1362-0347


  3 in total

1.  Emotion-related impulsivity and rumination: Unique and conjoint effects on suicidal ideation, suicide attempts, and nonsuicidal self-injury across two samples.

Authors:  Sheri L Johnson; Morgan Robison; Sarah Anvar; Benjamin A Swerdlow; Kiara R Timpano
Journal:  Suicide Life Threat Behav       Date:  2022-03-07

2.  Citizens' opinions and experiences related to costs and reimbursements for medications in times of retrenchment: cross-sectional population surveys in 2015 and 2017.

Authors:  Katri Aaltonen; Mikko Niemelä; Irene Prix
Journal:  Int J Equity Health       Date:  2022-03-09

3.  Liquorice ingestion attenuates vasodilatation via exogenous nitric oxide donor but not via β2-adrenoceptor stimulation.

Authors:  Elina J Hautaniemi; Antti J Tikkakoski; Arttu Eräranta; Mika Kähönen; Esa Hämäläinen; Ursula Turpeinen; Heini Huhtala; Jukka Mustonen; Ilkka H Pörsti
Journal:  PLoS One       Date:  2019-10-18       Impact factor: 3.240

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.